Correlation Between Reneo Pharmaceuticals and Sana Biotechnology
Can any of the company-specific risk be diversified away by investing in both Reneo Pharmaceuticals and Sana Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reneo Pharmaceuticals and Sana Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reneo Pharmaceuticals and Sana Biotechnology, you can compare the effects of market volatilities on Reneo Pharmaceuticals and Sana Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reneo Pharmaceuticals with a short position of Sana Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reneo Pharmaceuticals and Sana Biotechnology.
Diversification Opportunities for Reneo Pharmaceuticals and Sana Biotechnology
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Reneo and Sana is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Reneo Pharmaceuticals and Sana Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sana Biotechnology and Reneo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reneo Pharmaceuticals are associated (or correlated) with Sana Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sana Biotechnology has no effect on the direction of Reneo Pharmaceuticals i.e., Reneo Pharmaceuticals and Sana Biotechnology go up and down completely randomly.
Pair Corralation between Reneo Pharmaceuticals and Sana Biotechnology
Given the investment horizon of 90 days Reneo Pharmaceuticals is expected to generate 0.61 times more return on investment than Sana Biotechnology. However, Reneo Pharmaceuticals is 1.64 times less risky than Sana Biotechnology. It trades about 0.36 of its potential returns per unit of risk. Sana Biotechnology is currently generating about -0.24 per unit of risk. If you would invest 1,700 in Reneo Pharmaceuticals on September 30, 2024 and sell it today you would earn a total of 120.00 from holding Reneo Pharmaceuticals or generate 7.06% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 9.38% |
Values | Daily Returns |
Reneo Pharmaceuticals vs. Sana Biotechnology
Performance |
Timeline |
Reneo Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Strong
Sana Biotechnology |
Reneo Pharmaceuticals and Sana Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Reneo Pharmaceuticals and Sana Biotechnology
The main advantage of trading using opposite Reneo Pharmaceuticals and Sana Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reneo Pharmaceuticals position performs unexpectedly, Sana Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sana Biotechnology will offset losses from the drop in Sana Biotechnology's long position.Reneo Pharmaceuticals vs. Prime Medicine, Common | Reneo Pharmaceuticals vs. Ginkgo Bioworks Holdings | Reneo Pharmaceuticals vs. Ocean Biomedical | Reneo Pharmaceuticals vs. Royalty Pharma Plc |
Sana Biotechnology vs. Olema Pharmaceuticals | Sana Biotechnology vs. Cullinan Oncology LLC | Sana Biotechnology vs. Zentalis Pharmaceuticals Llc | Sana Biotechnology vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |